New diabetes pill shows Real-World promise in saudi study
NCT ID NCT05230589
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 43 times
Summary
This study looked at how well the once-daily pill Rybelsus® works for adults with type 2 diabetes in Saudi Arabia. Researchers tracked changes in blood sugar and body weight over 8-10 months. Participants took the medication as prescribed by their doctor and filled out a questionnaire about their experience. The goal was to see if this treatment helps control diabetes in everyday life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Saudi
Riyadh, 3542, Saudi Arabia
-
Specialized Medical Cente
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.